Integra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues

Dow Jones

2025/10/31

By Kelly Cloonan

Shares of Integra LifeSciences slid as the company cut its full-year outlook after supply chain interruptions dragged on revenue growth in its latest quarter.

The stock dropped 25% to $11.62 on Thursday. Shares are down 49% this year.

The medical technology company now forecasts adjusted earnings per share of $2.19 to $2.24 for the year, lowering the upper range of its prior projection of $2.19 to $2.29.

Integra also cut its revenue outlook, guiding for sales of $1.62 billion to $1.64 billion, compared to $1.66 billion to $1.68 billion previously.

The updated guidance comes after Integra said third-quarter revenue was negatively affected by two supply interruptions. Chief Executive Mojdeh Poul said the company is working to strengthen its supply chain and quality management system, and is confident it can improve overall performance.

For the third quarter, Integra narrowed its loss to $5.4 million, or 7 cents a share, from a loss of $10.7 million, or 14 cents a share, a year earlier.

Adjusted earnings per share were 54 cents, ahead of estimates of 43 cents a share according to analysts polled by FactSet.

Revenue rose 5.6% to $402.1 million, missing analyst expectations of $414.2 million.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

October 30, 2025 12:14 ET (16:14 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2579124024"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579124024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579124024?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 00:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579124024","market":"fut","top_or_hot":-1,"title":"Integra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Integra LifeSciences slid as the company cut its full-year outlook after supply chain interruptions dragged on revenue growth in its latest quarter. \n</p>\n<p>\n  The stock dropped 25% to $11.62 on Thursday. Shares are down 49% this year. \n</p>\n<p>\n  The medical technology company now forecasts adjusted earnings per share of $2.19 to $2.24 for the year, lowering the upper range of its prior projection of $2.19 to $2.29. \n</p>\n<p>\n  Integra also cut its revenue outlook, guiding for sales of $1.62 billion to $1.64 billion, compared to $1.66 billion to $1.68 billion previously. \n</p>\n<p>\n  The updated guidance comes after Integra said third-quarter revenue was negatively affected by two supply interruptions. Chief Executive Mojdeh Poul said the company is working to strengthen its supply chain and quality management system, and is confident it can improve overall performance. \n</p>\n<p>\n  For the third quarter, Integra narrowed its loss to $5.4 million, or 7 cents a share, from a loss of $10.7 million, or 14 cents a share, a year earlier. \n</p>\n<p>\n  Adjusted earnings per share were 54 cents, ahead of estimates of 43 cents a share according to analysts polled by FactSet. \n</p>\n<p>\n  Revenue rose 5.6% to $402.1 million, missing analyst expectations of $414.2 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 30, 2025 12:14 ET (16:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-10-31 00:14</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Integra LifeSciences slid as the company cut its full-year outlook after supply chain interruptions dragged on revenue growth in its latest quarter. \n</p>\n<p>\n  The stock dropped 25% to $11.62 on Thursday. Shares are down 49% this year. \n</p>\n<p>\n  The medical technology company now forecasts adjusted earnings per share of $2.19 to $2.24 for the year, lowering the upper range of its prior projection of $2.19 to $2.29. \n</p>\n<p>\n  Integra also cut its revenue outlook, guiding for sales of $1.62 billion to $1.64 billion, compared to $1.66 billion to $1.68 billion previously. \n</p>\n<p>\n  The updated guidance comes after Integra said third-quarter revenue was negatively affected by two supply interruptions. Chief Executive Mojdeh Poul said the company is working to strengthen its supply chain and quality management system, and is confident it can improve overall performance. \n</p>\n<p>\n  For the third quarter, Integra narrowed its loss to $5.4 million, or 7 cents a share, from a loss of $10.7 million, or 14 cents a share, a year earlier. \n</p>\n<p>\n  Adjusted earnings per share were 54 cents, ahead of estimates of 43 cents a share according to analysts polled by FactSet. \n</p>\n<p>\n  Revenue rose 5.6% to $402.1 million, missing analyst expectations of $414.2 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 30, 2025 12:14 ET (16:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2579124024","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579124024","pubTimestamp":1761840840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Integra LifeSciences slid as the company cut its full-year outlook after supply chain interruptions dragged on revenue growth in its latest quarter.The stock dropped 25% to $11.62 on Thursday. Shares are down 49% this year.The medical technology company now forecasts adjusted earnings per share of $2.19 to $2.24 for the year, lowering the upper range of its prior projection of $2.19 to $2.29.Integra also cut its revenue outlook, guiding for sales of $1.62 billion to $1.64 billion, compared to $1.66 billion to $1.68 billion previously.The updated guidance comes after Integra said third-quarter revenue was negatively affected by two supply interruptions. Chief Executive Mojdeh Poul said the company is working to strengthen its supply chain and quality management system, and is confident it can improve overall performance.For the third quarter, Integra narrowed its loss to $5.4 million, or 7 cents a share, from a loss of $10.7 million, or 14 cents a share, a year earlier.Adjuste","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","IART":"英特格拉生命科学"},"translate_title":"Integra LifeSciences因供应链问题下调财年前景而股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IART":0.9},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Shares of Integra LifeSciences slid as the company cut its full-year outlook after supply chain interruptions dragged on revenue growth in its latest quarter. \n\n\n  The stock dropped 25% to $11.62 on Thursday. Shares are down 49% this year. \n\n\n  The medical technology company now forecasts adjusted earnings per share of $2.19 to $2.24 for the year, lowering the upper range of its prior projection of $2.19 to $2.29. \n\n\n  Integra also cut its revenue outlook, guiding for sales of $1.62 billion to $1.64 billion, compared to $1.66 billion to $1.68 billion previously. \n\n\n  The updated guidance comes after Integra said third-quarter revenue was negatively affected by two supply interruptions. Chief Executive Mojdeh Poul said the company is working to strengthen its supply chain and quality management system, and is confident it can improve overall performance. \n\n\n  For the third quarter, Integra narrowed its loss to $5.4 million, or 7 cents a share, from a loss of $10.7 million, or 14 cents a share, a year earlier. \n\n\n  Adjusted earnings per share were 54 cents, ahead of estimates of 43 cents a share according to analysts polled by FactSet. \n\n\n  Revenue rose 5.6% to $402.1 million, missing analyst expectations of $414.2 million. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 12:14 ET (16:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}